Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP793421.RAtLDKbjTWnZasg_FTyla5v1Mjg91pZS0dQL5HIBSuf0A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP793421.RAtLDKbjTWnZasg_FTyla5v1Mjg91pZS0dQL5HIBSuf0A130_assertion type Assertion NP793421.RAtLDKbjTWnZasg_FTyla5v1Mjg91pZS0dQL5HIBSuf0A130_head.
- NP793421.RAtLDKbjTWnZasg_FTyla5v1Mjg91pZS0dQL5HIBSuf0A130_assertion description "[In addition, most of the gastric adenocarcinoma cases with CD99 down-regulation had reduced expression of SP1 (47 of 103, 45.6%; P<0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP793421.RAtLDKbjTWnZasg_FTyla5v1Mjg91pZS0dQL5HIBSuf0A130_provenance.
- NP793421.RAtLDKbjTWnZasg_FTyla5v1Mjg91pZS0dQL5HIBSuf0A130_assertion evidence source_evidence_literature NP793421.RAtLDKbjTWnZasg_FTyla5v1Mjg91pZS0dQL5HIBSuf0A130_provenance.
- NP793421.RAtLDKbjTWnZasg_FTyla5v1Mjg91pZS0dQL5HIBSuf0A130_assertion SIO_000772 17473187 NP793421.RAtLDKbjTWnZasg_FTyla5v1Mjg91pZS0dQL5HIBSuf0A130_provenance.
- NP793421.RAtLDKbjTWnZasg_FTyla5v1Mjg91pZS0dQL5HIBSuf0A130_assertion wasDerivedFrom befree-20140225 NP793421.RAtLDKbjTWnZasg_FTyla5v1Mjg91pZS0dQL5HIBSuf0A130_provenance.
- NP793421.RAtLDKbjTWnZasg_FTyla5v1Mjg91pZS0dQL5HIBSuf0A130_assertion wasGeneratedBy ECO_0000203 NP793421.RAtLDKbjTWnZasg_FTyla5v1Mjg91pZS0dQL5HIBSuf0A130_provenance.